Endocrine Community Makes Progress in Advancing EU EDC Regulations

In recent weeks, organizations around the world have intensified their lobbying efforts for better regulation of endocrine-disrupting chemicals (EDCs) and the Endocrine Society’s members continue to play a leading role as the voice of science in high-level discussions.

In the European Union, the Commission is under a tight deadline to deliver reforms to the regulation on Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH), which governs restrictions on EDCs. To ensure prioritization of this reform we partnered with the European Society of Endocrinology (ESE) to organize a petition to Commission President Ursula von der Leyen emphasizing the urgent need to deliver a legislative proposal to revise REACH by June 2023. The petition was co-signed by 44 European and international endocrine-focused scientific societies and delivered to members of the European Parliament and other policymakers with an interest in EDCs. The petition generated significant attention and was reported on by Politico EU noting our “United Front.”

Organizations around the world have intensified their lobbying efforts for better regulation of endocrine-disrupting chemicals and the Endocrine Society’s members continue to play a leading role as the voice of science in high-level discussions.

Additionally, we signed a letter organized by the European Environment Bureau and supported by 11 other members of a high-level strategic advisory group on chemicals and sustainability to urge the European Commissioner for the Internal Market, Thierry Breton, to support a prompt revision of REACH to ensure harmonized and predictable regulatory approaches to chemicals, including EDCs, across the EU. Reforms to the REACH regulation are necessary to ensure that new regulatory classes that identify hazardous EDCs can be implemented to reduce exposure to these harmful chemicals.

You may also like

  • Endocrine Society Advocacy Update – March 2024

    Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before…

  • Advocacy Update: February 2024

    Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs…